期刊文献+

KISS-1和VEGF-C在乳头状甲状腺癌组织中的表达及临床意义

EXPRESSION AND CLINICAL SIGNIFICANCE OF KISS-1 AND VEGF-C IN PAPILLARY CARCINOMA OF THE THYROID
下载PDF
导出
摘要 目的研究KISS-1、VEGF-C在乳头状甲状腺癌组织中的表达情况,分析两者表达与乳头状甲状腺癌临床病理特征的关系以及两者的相关性。方法收集乳头状甲状腺癌组织病理标本48例及其正常甲状腺组织20例,采用免疫组织化学SP法检测KISS-1、VEGF-C在乳头状甲状腺癌组织中的表达情况,分析KISS-1、VEGF-C在乳头状甲状腺癌组织中阳性表达率与临床病理学特征之间的关系以及两者表达之间的相关性。结果 KISS-1、VEGF-C在乳头状甲状腺癌组织和正常甲状腺组织中的阳性表达率之间具有显著性差异(P<0.01)。KISS-1、VEGF-C在乳头状甲状腺癌组织中的阳性表达率与肿瘤大小、颈部淋巴结转移、临床分期相关且均有显著性差异(P<0.05)。KISS-1和VEGF-C的表达与患者的性别、年龄均无关(P>0.05);KISS-1与VEGF-C在乳头状甲状腺癌组织表达存在负相关关系(P<0.05)。结论 KISS-1、VEGF-C的表达水平与乳头状甲状腺癌有关,且与肿瘤大小、颈部淋巴结转移状况、临床分期相关,与患者性别、年龄无关。KISS-1在乳头状甲状腺癌组织的表达与VEGF-C呈负相关关系。KISS-1、VEGF-C联合检测可作为乳头状甲状腺癌恶性潜能的判断指标。 Objective To study the expression of KISS - 1 and vascular endothelial growth factor ( VEGF - C) in papillary carcinoma of the thyroid and the association with the clinical pathological features of the malignancy, and to analyze the correlation between the expression of KISS - 1 and VEGF - C. Methods To analyze the correla- tion between the protein expression rate and clinical and pathological characters, and also the correlation between the expression of KISS - 1 and VEGF - C by detecting the expression of KISS - 1 and VEGF - C in 48 papillary carcinoma of the thyroid tissues and 20 normal thyroid tissues by using the immunohistochemistry SP method. Re- suits The positive expression rate of KISS - 1 and VEGF - C was significantly different between papillary carcinoma of the thyroid tissues and normal thyroid tissues( P 〈 0. 01 ). The positive expression rate of KISS - 1 and VEGF - C in papillary carcinoma of the thyroid tissues was quite different because of different tumor sizes, cervical lymph node metastasis and clinical stages ( P 〈 0.05 ), but there was no close correlation with sex and age ( P 〉 0.05 ). The nega- tive correlation showed in KISS - 1 and VEGF - C (P 〈 0.05 ). Conclusion The results demonstrate that the expres- sion level of KISS - 1 and VEGF - C is correlated with papillary carcinoma of the thyroid, tumor size, cervical lymph node metastasis and clinical stages, but there is no close correlation with sex and age. The negative correlation exists in KISS - 1 and VEGF - C. The joint detection of KISS - 1 and VEGF - C may be important in the judgment of the potential malignant of thyroid carcinoma.
出处 《青海医学院学报》 CAS 2013年第3期194-198,共5页 Journal of Qinghai Medical College
关键词 KISS-1 VEGF-C乳头状甲状腺癌表达意义 KISS - 1 VEGF - C Papillary carcinoma of the thyroid Expression Significance
  • 相关文献

参考文献5

  • 1黄韬.分化型甲状腺癌的规范治疗[J].中国普外基础与临床杂志,2012,19(8):805-808. 被引量:32
  • 2Ito Y, Higashiyama T, Takamura Y, et al. Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metasta- sis : validity of prophylactic modified radical neck dissection [ J ]. World J Surg,2007,31 ( 11 ) : 2085 - 2091.
  • 3Ringel MD, Hardy E, Bemet VJ, et al. Metastin recep- tor is overexpressed in papillary thyroid cancer and activates MAP kinase in thyroid cancer cells [ J ]. J Clin EndocrinolMetab,2002,87 (5) :2399 - 2402.
  • 4Becker JA, Mirjolet JF, Bernard J, et al. Activation of GPR54 promotes cell cycle arrest and apoptosis of human tumor cell through a specific transcriptional program not shared by oth- er G q - coupled receptors [ J ]. Biochemi Biophys Res Commun, 2004,326 (3) :677 - 686.
  • 5Jennbacken K, Vallbo C, Wang W, et al. Expression of vascular endothelial growth factor C ( VEGF - C) and VEGF re- ceptor- 3 in human prostate cancer associated with regional lymph node metastasis [ J ]. Prostate,2005,65 (2) : 110 - 116.

二级参考文献19

  • 1Sherman SI. Thyroid carcinoma [J]. Lancet, 2003, 361(9356): 501-511.
  • 2Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012 [J]. CA Cancer J Clin, 2012, 62(1): 10-29.
  • 3Simard EP, Ward EM, Siegel R, et al. Cancers with increasing incidence trends in the United States: 1999 through 2008 [J]. CA Cancer J Clin, 2012 ; 62(2) : 118-128.
  • 4Mazzaferri EL, Kloos RT. Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer [J]. J Clin Endocrinol Metab, 2001, 86(4): 1447-1463.
  • 5Hay ID, Grant CS, Bergstralh EJ, et al. Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES lowrisk papillary thyroid carcinoma? [J]. Surgery, 1998, 124(6) 958-966.
  • 6Massin JP, Savoie JC, Gamier H, et al. Pulmonary metastases in differentiated thyroid carcinoma. Study of 58 cases with implications for the primary tumor treatment [J]. Cancer, 1984, 53(4): 982-992.
  • 7Simon D, Goretzki PE, Witte J, et al. Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma [J]. World J Surg, 1996, 20(7): 860-866.
  • 8Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer [J]. AmJ Med, 1994, 97(5): 418-428.
  • 9Cooper DS, Doherty GM, Haugen BR, et al. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer [J]. Thyroid, 2009, 19(11): 1167-1214.
  • 10NCCN Guidelines Version 2. 2012 thyroid carcinoma [EB\OL]. http://www. neen. org/professionals/physician_gls/pdf/thyroid. pdf.

共引文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部